|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0019169,
umls-concept:C0030705,
umls-concept:C0205171,
umls-concept:C0205179,
umls-concept:C0209738,
umls-concept:C0596545,
umls-concept:C0854866,
umls-concept:C1328050,
umls-concept:C1708528,
umls-concept:C1831743,
umls-concept:C2607850
|
|
pubmed:issue |
15
|
|
pubmed:dateCreated |
2009-9-18
|
|
pubmed:abstractText |
Hepatitis B virus (HBV) reactivation is a well-known complication in cancer patients receiving cytotoxic chemotherapy, resulting in varying degrees of liver damage. The objective of this study was to investigate the efficacy of lamivudine for the prevention of HBV reactivation in non-Hodgkin's lymphoma (NHL) patients undergoing high-dose chemotherapy and autologous hematopoietic stem cell transplantation (AHSCT).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
1744-7666
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
10
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2399-406
|
|
pubmed:meshHeading |
pubmed-meshheading:19761353-Adult,
pubmed-meshheading:19761353-Antineoplastic Agents,
pubmed-meshheading:19761353-Combined Modality Therapy,
pubmed-meshheading:19761353-Female,
pubmed-meshheading:19761353-Hematopoietic Stem Cell Transplantation,
pubmed-meshheading:19761353-Hepatitis B,
pubmed-meshheading:19761353-Hepatitis B e Antigens,
pubmed-meshheading:19761353-Hepatitis B virus,
pubmed-meshheading:19761353-Humans,
pubmed-meshheading:19761353-Incidence,
pubmed-meshheading:19761353-Lamivudine,
pubmed-meshheading:19761353-Lymphoma, Non-Hodgkin,
pubmed-meshheading:19761353-Male,
pubmed-meshheading:19761353-Middle Aged,
pubmed-meshheading:19761353-Prospective Studies,
pubmed-meshheading:19761353-Reverse Transcriptase Inhibitors,
pubmed-meshheading:19761353-Severity of Illness Index,
pubmed-meshheading:19761353-Transplantation, Autologous,
pubmed-meshheading:19761353-Young Adult
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Lamivudine for the prevention of hepatitis B virus reactivation after high-dose chemotherapy and autologous hematopoietic stem cell transplantation for patients with advanced or relapsed non-Hodgkin's lymphoma single institution experience.
|
|
pubmed:affiliation |
Sun Yat-sen University, Cancer Center, Department of Medical Oncology, Guangzhou 510060, PR China. huang_sysu@163.com
|
|
pubmed:publicationType |
Journal Article,
Controlled Clinical Trial
|
